Invention Grant
- Patent Title: Azetidine derivatives useful as modulators of cortical cathecolaminergic neurotransmission
-
Application No.: US15574796Application Date: 2016-05-20
-
Publication No.: US10087142B2Publication Date: 2018-10-02
- Inventor: Fredrik Pettersson , Clas Sonesson
- Applicant: Integrative Research Laboratories Sweden AB
- Applicant Address: SE Göteborg
- Assignee: INTEGRATIVE RESEARCH LABORATORIES
- Current Assignee: INTEGRATIVE RESEARCH LABORATORIES
- Current Assignee Address: SE Göteborg
- Agency: Ballard Spahr LLP
- Priority: EP15168373 20150520; SE1650485 20160411
- International Application: PCT/EP2016/061479 WO 20160520
- International Announcement: WO2016/185032 WO 20161124
- Main IPC: C07D205/04
- IPC: C07D205/04 ; A61P25/28 ; A61P25/18 ; A61P25/22 ; A61P25/14
Abstract:
The present disclosure relates to certain novel compounds of Formula (I) and to their utility in modulation of levels of monoamines, dopamine, norepinephrine and serotonin, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders.
Public/Granted literature
- US20180141903A1 NOVEL AZETIDINE DERIVATIVES USEFUL AS MODULATORS OF CORTICAL CATHECOLAMINERGIC NEUROTRANSMISSION Public/Granted day:2018-05-24
Information query
